AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+33.49%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.83B
AUM Growth
+$3.83B
Cap. Flow
-$4.23B
Cap. Flow %
-110.43%
Top 10 Hldgs %
84.96%
Holding
115
New
10
Increased
27
Reduced
10
Closed
11

Sector Composition

1 Consumer Discretionary 54.99%
2 Healthcare 44.37%
3 Energy 0%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FBRX icon
76
Forte Biosciences
FBRX
$137M
$934K 0.02% 100,000
TRIL
77
DELISTED
Trillium Therapeutics Inc.
TRIL
$900K 0.02% 150,000
NVAX icon
78
Novavax
NVAX
$1.21B
$670K 0.01% 500,000
ATYR
79
aTyr Pharma
ATYR
$527M
$455K 0.01% 500,000
SNDX icon
80
Syndax Pharmaceuticals
SNDX
$1.41B
$426K 0.01% 60,697 -89,303 -60% -$627K
IMDX
81
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
$383K 0.01% 150,000
BAC icon
82
Bank of America
BAC
$376B
0
BMRN icon
83
BioMarin Pharmaceuticals
BMRN
$11.2B
0
BMY icon
84
Bristol-Myers Squibb
BMY
$96B
0
CAT icon
85
Caterpillar
CAT
$196B
0
CVX icon
86
Chevron
CVX
$324B
0
DVAX icon
87
Dynavax Technologies
DVAX
$1.19B
0
EDIT icon
88
Editas Medicine
EDIT
$231M
-25,000 Closed -$829K
EXEL icon
89
Exelixis
EXEL
$10.1B
0
FCX icon
90
Freeport-McMoran
FCX
$63.7B
0
GM icon
91
General Motors
GM
$55.8B
0
GS icon
92
Goldman Sachs
GS
$226B
0
IBB icon
93
iShares Biotechnology ETF
IBB
$5.6B
0
IBM icon
94
IBM
IBM
$227B
0
INCY icon
95
Incyte
INCY
$16.5B
-300,000 Closed -$25M
IQ icon
96
iQIYI
IQ
$2.55B
-750,000 Closed -$11.7M
KURA icon
97
Kura Oncology
KURA
$686M
-100,000 Closed -$1.88M
MS icon
98
Morgan Stanley
MS
$240B
0
NBIX icon
99
Neurocrine Biosciences
NBIX
$13.8B
0
NERV icon
100
Minerva Neurosciences
NERV
$16.5M
-300,000 Closed -$1.88M